Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma
Clinical trial NCT05160285 · UNKNOWN
Trial details
- NCT number
- NCT05160285
- Sponsor
- YULISU
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-25
- Primary completion
- 2023-12-15
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.